Open AccessAnkle-brachial index: more than a diagnostic test?
Author(s) -
Ludwig Cáceres-Farfán,
Milagros Moreno-Loaiza,
W Samir Cubas
Publication year - 2021
Publication title -
archivos peruanos de cardiología y cirugía cardiovascular
Language(s) - English
Resource type - Journals
ISSN - 2708-7212
DOI - 10.47487/apcyccv.v2i4.168
Subject(s) - medicine , ankle , diabetes mellitus , cardiology , coronary artery disease , arterial disease , blood pressure , disease , peripheral , stroke (engine) , pathological , physical therapy , vascular disease , surgery , mechanical engineering , engineering , endocrinology
The ankle-brachial index (ABI) is the relationship between the systolic blood pressure taken at the ankle level and the brachial artery. A pathological ABI ( 1.40) indicates the presence of peripheral artery disease (PAD). Many studies indicate the great utility of this test in the diagnosis of PAD due to its ease of use, reproducibility, low cost, and high cost-effectiveness. This evaluation can be directly correlated with cardiovascular morbidity and mortality; however, it has recently been confirmed that a low ABI can be a predictor of major cardiovascular events, as it is related to diabetes mellitus, chronic coronary disease, stroke, and more. The objective of this work was to review the current evidence on the importance of ABI in the diagnosis of PAD and its main role as a predictor of cardiovascular morbidity and mortality.